Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close

Whitepapers

Long-Acting Muscarinic Agents (LAMAs) – A New Frontier for COPD and Asthma Treatment

Chronic obstructive pulmonary disease (COPD) is a major global health problem with a rising
incidence and morbidity representing an important public health challenge that is both preventable and treatable. It has been estimated that in 2030 COPD will be the fourth leading cause of death worldwide resulting in an economic and social burden that is both substantial and increasing.